Literature DB >> 9587060

IL-4 addition during differentiation of CD34 progenitors delays maturation of dendritic cells while promoting their survival.

N Rougier1, D Schmitt, C Vincent.   

Abstract

Dendritic cells (DC) are the most effective cells for antigen presentation in primary immune responses. Human cord blood CD34+ progenitors cultured in the presence of GM-CSF and TNF alpha generate a heterogeneous population of DC including Langerhans-like DC (LLDC) and monocytes. We describe here that IL-4 exerts different effecs in such culture according to the cells considered. Thus, IL-4 favors DC components at the expense of monocytic development, and permits long-time persistence of DC which can be maintained up to one month in culture. These results show an IL-4-dependent inhibition of proliferation and emergence of CD14+ cells. Notably, however, IL-4 also acts on the DC precursors. Thus, IL-4 enhances survival and delays maturation of LLDC from CD1a+ CD14- precursors. In addition, IL-4 also favors orientation of CD14+ CD1a- DC/monocyte precursors towards dermal-type CD1a+ DC. DC recovered from IL-4 treated cultures display reduced allostimulatory capacity, but this function is restored upon IL-4 weaning. Finally, a short (48h) IL-4 pulse is sufficient to favor DC development. The present study demonstrates that IL-4 positively regulates DC development at several levels on distinct precursor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9587060     DOI: 10.1016/S0171-9335(98)80124-6

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  5 in total

1.  Presence of circulating abnormal CD34+ progenitors in adult Langerhans cell histiocytosis.

Authors:  L Misery; N Rougier; B Crestani; M Faure; A Claudy; D Schmitt; C Vincent
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

2.  A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity.

Authors:  Lifeng Wang; Lisa Rollins; Qinlong Gu; Si-Yi Chen; Xue F Huang
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

3.  Binding of live conidia of Aspergillus fumigatus activates in vitro-generated human Langerhans cells via a lectin of galactomannan specificity.

Authors:  F Persat; N Noirey; J Diana; M-J Gariazzo; D Schmitt; S Picot; C Vincent
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

Review 4.  Lipid-Reactive T Cells in Immunological Disorders of the Lung.

Authors:  Seungwon Ryu; Joon Seok Park; Hye Young Kim; Ji Hyung Kim
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561

5.  Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancer.

Authors:  Navneet S Majhail; Mohamad Hussein; Thomas E Olencki; George T Budd; Laura Wood; Paul Elson; Ronald M Bukowski
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.651

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.